BruniCNgcozanaTBraschiF, et al. Preliminary validation of the digital ulcer clinical assessment score in systemic sclerosis. J Rheumatol2019; 46(6): 603–608.
3.
IngegnoliFSchioppoTAllanoreY, et al. Practical suggestions on intravenous iloprost in Raynaud’s phenomenon and digital ulcer secondary to systemic sclerosis: systematic literature review and expert consensus. Semin Arthritis Rheum2019; 48(4): 686–693.
4.
Matucci-CerinicMBruniCAllanoreY, et al. Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management. Ann Rheum Dis2020; 79(6): 724–726.
5.
AvouacJAiróPCarlierN, et al. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab. Ann Rheum Dis. Epub ahead of print 5 June 2020. DOI: 10.1136/annrheumdis-2020-217864.
6.
OrlandiMLepriGBruniC, et al. The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress. Clin Rheumatol2020; 39(7): 2043–2047.
